December 3rd, 2020 | by BTP Admin
The Suites by Graystone has the opportunity to work and build relationships with incredible businesses and their teams and working with TeleMedC is no different. We sat down with CEO, Founder and Chair of the Board, Para Segaram to tell us more about TeleMedC as they are paving the way for accessible retinal imaging with Artificial Intelligence software.
What is TeleMedC currently working on?
We are currently working on portable, retinal image grading technologies that will be delivered at low-cost to pharmacies, community clinics and primary care providers in the world market. This technology automates and speeds up the diagnosis and detection of many chronic eye diseases including Diabetic Retinopathy and Glaucoma.
What Is Diabetic Retinopathy?
Diabetes affects over 1.7 million Australians and one third show signs of Diabetic Retinopathy. Diabetic Retinopathy is a condition where blood vessels in the back of the eye begin to bleed. As the condition worsens the leakage damages the patient’s eyesight. For diabetics, it is the world’s leading cause of vision loss or even blindness.
How does the device work?
Our portable scanning device, the EyeScan R2 is a fundus imaging camera, a non-invasive device that takes photos of the back of the eye. Due to its relative small size and low price in comparison to much larger, more expensive cameras that can only be found at eye specialists’ clinics and/or hospitals, it allows Family/GP clinics, pharmacies, etc. to have an easy to use camera to screen Diabetic Retinopathy and other eye diseases in a fast, efficient and very accurate way. Our AI Diabetic software has been TGA certified in Australia, CE marked in Europe and HSA certified in Singapore.
How will this technology help in future?
Our screening/grading system will greatly help vast numbers of people to be screened whom, otherwise would not check their eyes. It is/will be extremely useful in the prevention of Diabetic Retinopathy, a precursor of Diabetes. These eye screenings are very accurate (97%), very fast (within 2 minutes) and very affordable.
Our combined system of the EyeScan2 + our integrated AI technology can be placed in any family clinic or pharmacy where people can be screened without the need to go to an eye specialist. It is the first step towards a predictive and preventive eye care. It is significantly less expensive and less time consuming than a visit to an eye doctor: it is fast, reliable and affordable.
Our system not only detects the disease as it grades the disease as mild, moderate or severe alerting the patient to see an eye specialist if necessary. A referral can be given at the time if performed during a GP visit. This allows patients to be screened as part of an overall health check and work with the GP in the best way to manage the disease. Further to this, by making screenings affordable and available in many locations allows a vast number of people, who would not otherwise be screened. It decreases the overall burden on hospitals allowing the eye specialists/surgeons to focus on the most needed cases and eye surgeries, reducing the overall costs of healthcare.
Having our system in place as a basic tool in predicting and preventing eye disease allows large populations to have access to affordable and easy eye screenings that if not timely detected can lead to unnecessary blindness.
For more information on TeleMedC please visit https://www.telemedc.com/.